# RISK Stratification Using a Combination of Cardiac Troponin T and Brain Natriuretic Peptide in Patients Receiving CRT-D

> **NCT00453622** · — · COMPLETED · sponsor: **Abbott Medical Devices** · enrollment: 222 (actual)

## Conditions studied

- Heart Failure

## Interventions

- **DEVICE:** Cardiac Resynchronization Therapy-Defibrillator

## Key facts

- **NCT ID:** NCT00453622
- **Lead sponsor:** Abbott Medical Devices
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2005-11
- **Primary completion:** 2012-08
- **Final completion:** 2012-08
- **Target enrollment:** 222 (ACTUAL)
- **Last updated:** 2019-02-04

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00453622

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00453622, "RISK Stratification Using a Combination of Cardiac Troponin T and Brain Natriuretic Peptide in Patients Receiving CRT-D". Retrieved via AI Analytics 2026-08-18 from https://api.ai-analytics.org/clinical/NCT00453622. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*